Harnessing the power of the immune system to treat cancer and other diseases

Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.


Chen Schor photo

Chen Schor

President and Chief Executive Officer

blake aftab photo

Blake Aftab, Ph.D.

Senior Vice President and Chief Scientific Officer

Francesco Galimi photo

Francesco Galimi, M.D., Ph.D.

Chief Medical Officer

Nick Harvey photo

Nick Harvey

Chief Financial Officer

Don Healey photo

Don Healey, Ph.D.

Chief Technology Officer

Board of Directors

Steve Dubin


Aya Jakobovits, Ph.D.

Founder, Director, Senior Strategic Advisor

Chen Schor

Director, President and Chief Executive Officer

Andrew Sinclair, Ph.D.


Scientific Advisory Board